Debt has Grown Out of Control - BrokerBank Securities, Inc.

May 20, 2015, 07:00 ET from BrokerBank Securities, Inc.

NEW YORK, May 20, 2015 /PRNewswire/ -- Medican Enterprises Inc. (OTCBB: MDCN) is a bio-pharmaceutical company at the forefront of wholesale medical marijuana ("MMJ") production, cultivation, and wholesale distribution of cannabis related products. Medican through its subsidiaries, is seeking to invest in businesses associated with the growing, marketing, research and development, training, distribution and retail sale of medical and recreational marijuana, both in the United States and Canada.

The company's stocked popped up at the end of March when it announced its upcoming acquisition of a couple of properties in Arizona. But in out of the last ten sessions MDCN lost 82% of its value in a matter of just two weeks. Yesterday, it continued a 5% down and it closed the day at $0.0055 on a dollar volume of $414 thousand.

An analyst brief and recommendation can be viewed in its entirety by using the link below. There is no cost obligation required to view this report.

http://bit.ly/-MDCN-AnalystReport

Copy and paste to browser may be required.

FORWARD-LOOKING DISCLAIMER   

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.  

COMPLIANCE PROCEDURE   

Content is researched, written and reviewed on a best-effort basis. This report was prepared for informational purposes only.  Affiliated parties involved with producing and issuing this report have not been compensated in any form by profiled company.  A full disclaimer can be found by viewing the full analyst report. This document, article or report is written and authored by a 3rd party research analyst. However, we are only human and make mistakes. If you notice any errors or omissions, please notify us below.

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116

 

SOURCE BrokerBank Securities, Inc.



RELATED LINKS

http://www.brokerbanksecurities.com